Adel F. Al-Marzouki

Carbimazole-Induced Severe Acquired Aplastic Anemia in a Patient with Graves’ Disease: A Case Report

Background and Clinical Significance: Carbimazole is a widely used medication to treat Graves’ disease, although it can rarely cause acquired aplastic anemia, a complication that happens in less than 0.01% of people. Case Presentation: We report a 36-year-old woman treated with s...